Since 1971, more than 100 000 persons in England and Wales have been registered for cancer on more than one occasion; that is, about one in every 25 cancer registrations during the last 13 years has been the second or subsequent registration for that person. A1 per cent sample of these multiple cancer registrations for the decade 1971-1980 has been examined to assess their utility for studying the epidemiology of multiple primary malignancy in England and Wales.
Introduction
Study of multiple primary malignancy may provide information relevant to the prevention, causes and treatment of cancer 1 " 3 . The frequency of multiple malignancy appears to be rising, and may be expected to increase as survival from a first cancer improves, and as treatment regimens involving radiotherapy and chemotherapy, which are themselves potentially carcinogenic, become more widely used. This is particularly true of children, for whom improved survival from leukaemia and lymphoma, achieved with a combination of radiotherapy and multiple chemotherapy, is now often longer than the latent periods of irradiation and chemical carcinogenesis 4 . A population-based tumour registry, with good follow-up procedures and a large welldefined population, under observation for 10 or more years, would be capable of providing data to study the epidemiology of multiple primary malignancy 5 , providing that the completeness of cancer registration and the efficiency of linkage between two tumours in one person were both sufficiently high.
The National Cancer Registration scheme coordinated by the Office of Population Censuses and Surveys (OPCS) has collated cancer incidence data from regional cancer registries covering the whole of England and Wales since 1962 (Fig. 1) . National cancer incidence and survival statistics have been published annually, but no data are available on the incidence of second malignancies for England and Wales as a whole. Registries have been asked to record whether a tumour was involved in a multiple primary malignancy since 1979, but this facility has not yet been widely adopted. Individual registries do record multiple cancers, and the West Midlands registry has published incidence rates for certain combinations of first and second tumours 6~'°. Until 1971, it would only have been possible to study multiple tumours using regional registry data. However, there are several problems. Not all registries have computerised records or separate files for multiple cancer; record linkage efficiency varies between registries; people who migrate across registry boundaries in the interval between their first and second cancers will not be detected as having multiple primary cancer; and the population available to any one registry is relatively small. Even the largest registry, South Thames, covered less than 15 per cent of the national population until 1985, when it merged with the two north Thames registries.
In January 1971, however, a change in the national cancer registration scheme made it possible to study multiple primary malignancy for the whole of England and Wales. In order to obtain survival data for all registered cancer patients automatically, all cancer registrations and death certifications from that date were linked to a single alphabetic index, the National Health Service Central Register (NHSCR) at Southport. an unexpected by-product of the new system. If, instead of death, the next vital event to be recorded for a cancer patient was another cancer registration, the system now produced evidence of multiple cancer (Fig. 2 ). This change removed most of the problems of studying multiple cancer at the regional level. Linkage efficiency was high (more than 98 per cent of all cancer registrations have been successfully assigned to an individual's record in the index in each year since 1971) and largely independent of the cancer registry concerned; multiple cancer in migrants would be detected; and above all the entire national population would be covered. However, not all the many thousands of multiple tumour records would represent true multiple primary malignancy. Duplicate registration of a single tumour can arise, usually between two adjacent registries, if the patient is referred between hospitals on either side of their common boundary, even though the tumour should only be registered in the territory of residence. Less often, one registry will record the same tumour twice, perhaps because a name is mis-spelt during a second hospital admission. Such duplication may give rise to a multiple tumour record, when each registration is duly linked to the same person at NHSCR, even though the duplicate registration may already have been detected by the registry and cancelled from the current national cancer files (see Fig. 1 ). The multiple tumour records held at OPCS have been filed apart from other records, however, and have not been systematically used, so duplicate registrations cancelled from the current national files would still be represented among them.
A pilot study of OPCS multiple tumour records has now been done, with three objectives: first, to estimate the total number of multiple tumour records available for study; second, to assess the quality of those records for studying the epidemiology of multiple primary malignancy; and third, to estimate the number of true multiple primary malignancies registered in England and Wales since 1971. It was also the intention to assess the feasibility of separating registration errors from true multiple primaries, and to devise a method for studying the entire material if the pilot study suggested this to be worthwhile.
Material and methods
Multiple tumour records were defined as two or more tumour registrations linked to the same person at NHSCR and filed as a single unit at OPCS. Multiple records had been sorted by initial letter of surname within year of the latest registration, but no census was available. In order to obtain a representative sample of about 1 per cent of records, an approximate count of records in each year was made. A two-stage random sampling procedure was then adopted, stratifying on the year of most recent registration. Within each year a randomly chosen letter was used to identify a manageable number of records, which were accurately counted. A record was then sampled at random from within this block. The procedure was repeated until 1 per cent of the estimated number of records in that year had been sampled.
The site, registration date and identifying serial numbers and the patient's full name were recorded for each component tumour registration in the sampled multiple records. Missing items of data were found from the main national cancer registration files. Each regional cancer registry was then asked to examine a list of all the sampled records for which it had issued one or more of the original tumour registrations, and to ascertain the true relationship, if any, between the registrations in each record, after review of its files. In doubtful cases, original clinical records were checked, if still available. Registries were asked to assign each multiple record to one of seven categories (Table 1) , intended to be mutually exclusive, so that an unequivocal allocation to a single category could be made for each pair of tumour registrations. Multiple records containing more than two registrations could be assigned to more than one category, if necessary. The registries were also asked to state both the criteria used to decide whether multiple malignancy had Table 1 . Descriptive categories for OPCS multiple tumour records.
1.
Multiple primary malignancy 2.
Duplicate registration of a single tumour within your registry (within-registry duplicate) 3.
Duplicate registration of a single tumour by your registry and another registry (between-registry duplicate) 4.
Registration of metastases from a previously registered tumour 5.
Record not multiple: incorrect linkage by NHSCR of tumours registered to different persons 6.
Record not multiple: all except one registration previously cancelled (see text) 7.
Other error of linkage or registration occurred, and the method used to link first and subsequent tumours in one individual, and the method used to store information about multiple tumours. For most multiple records, all the tumours had arisen from a single registry, but registries were informed if another registry had also recorded a tumour for the same person, so that they could compare notes before categorising a multiple record. Only the 'index' registry, arbitrarily defined as the source of the most recent registration, was asked to assign a category to such multiple records.
Results
There were an estimated 44 800 multiple tumour records, in which each of the tumours concerned was registered in the decade 1971-80. During this period, at least 42 474 multiple records are known to have been sent to OPCS from the National Health Service Central Register at Southport ( Table 2 ). The number of multiple records arising between 1 January 1971 and 31 May 1974 was not recorded, but is unlikely to have exceeded 5000. A number of multiple records sent to OPCS in 1981-83 referred to 1980 or earlier, because of the delays inherent in the national cancer registration scheme (Fig. 2) . The estimate of 44 800 multiple records for 1971-80 is therefore likely to be an underestimate of the true figure. 
-(a) /V=448; 32 records with N.E. Thames as index registry were excluded, (b) These are duplicate registrations which have been cancelled since 1971, and removed from the main national cancer file; however, they had not been systematically removed from multiple records, (c) Index registry arbitrarily defined as the one which issued the most recent registration in a multiple record.
The sample yielded 448 records, for 325 (73 per cent) of which each of the two or more tumours was registered in the same regional registry; in the remainder, different registries had recorded a tumour in the same person. One registry (N.E. Thames) temporarily suspended operation during the survey, and since no assessment could be obtained for most of its 32 records, they were excluded. Replies were received from the other 13 registries for all of the remaining 416 records.
Eighteen multiple records (4 per cent, Table 3 ) involved a duplicate registration which had previously been deleted from the main national cancer file. These records will be describe as 'inactive', and the remainder, still held on the main file used to prepare cancer statistics, as 'active'. The distinction is relevant because a wider study of all multiple primary tumours using the national cancer file would automatically exclude cancelled duplicates. The distribution of multiple records into the various categories is shown in Table 3 . There were clear differences between multiple records originating from a single registry and those involving more than one registry.
Multiple primary malignancy
Among 398 active multiple records, 253 (64 per cent, or 61 per cent of the 416 records assessed) were reported as genuine multiple primary malignancy by the registries concerned, after review of their records. These results suggest that among the estimated 44 800 multiple tumour records for 1971-80, there may be 27 000 multiple primaries (61 per cent). If a similar proportion also applies to more recent records, there may be 61 000 multiple primaries in England and Wales among over 100 000 multiple tumour records that have arisen since 1971 ( Table 2) .
For 244 (96 per cent) of the multiple primary malignancies identified in the study, each of the two or more tumours involved was recorded by a single registry; they comprised the great majority (86 per cent) of the 283 records in which only one registry was involved (Table 3 ). This proportion (86 per cent) is a measure of the overall accuracy of multiple tumour registration within a single registry during the period of the study; the remaining 14 per cent of multiple tumour records from a single registry were previously undetected errors of registration. By contrast, only nine (4 per cent) of the 253 multiple primary malignancies involved two or more registries; they formed a small minority (8 per cent) of the 115 records in which more than one registry was involved. Again, this proportion (8 per cent) estimates the accuracy of multiple tumour registration when two or more registries are involved: 92 per cent of records in this category were previously undetected errors of registration.
Duplicate registration
In the sample as a whole, 152 (36 per cent) of the 416 multiple records were duplicate registrations of a single tumour: 18 (12 per cent) of these errors had previously been detected and the duplicate registration cancelled. The remainder (88 per cent) of the errors were disclosed for the first time by this study.
Two-thirds of the 152 duplicates (103; 68 per cent) arose as the result of two (usually adjacent) registries recording the same tumour (Table 3 ). Only one of these 103 duplicates had previously been detected and cancelled. A few arose because a different address was recorded at each hospital admission, but most duplicates occurred because patients with an address outside the cancer registry's territory were incorrectly registered as if they had been resident inside it.
Only one-third (49; 32 per cent) of the 152 duplicates arose within a single registry, and a third of these (17; 35 per cent) had already been detected and cancelled by the registry concerned. Among the 32 previously undetected duplicates, two-thirds could be attributed to a failure of the indexing system used by the registry to prevent duplicate registration. One-third of the undetected duplicates arose from the use of different names, or mis-spelling of names, at two hospital admissions for the same cancer over a short period of time. These duplicates were only detected because both registrations were eventually linked to the same person at NHSCR, even though the personal details recorded were not identical.
The number of undetected duplicate tumour registrations still on the main national cancer file can be estimated from these figures: 134 (32 per cent) of 416 records fell into this category. Among the estimated 44 800 multiple records for 1971-80, there may therefore be 14 000 undetected duplicates, representing less than 0-8 per cent of the 1-8 million tumours flagged at NHSCR for this period (Table 2 ).
Other errors of registration
Remarkably few multiple tumour records were ascribed to faulty registration of metastases from a previously registered tumour. In five of the eight records in this category, one tumour had been assigned a site-code in the range 195-9 (eighth revision of the International Classification of Diseases), reflecting the ill-defined nature or site of the neoplasm. Such records would not be accepted as a multiple primary malignancy. The rarity of this error appears to reflect stringent criteria applied by the registries before registration of a second tumour for the same individual.
No multiple tumour record was rejected by the registries because of incorrect linkage (at NHSCR) of two tumours registered to different persons: this is evidence that the high proportion of cancer registrations successfully flagged is achieved only after very thorough checks on the identity of the individual being flagged.
Discussion
This preliminary study of OPCS multiple tumour records suggests there may be 27 000 In order to study the very large number of multiple tumour records, which are not stored as such on magnetic tape, it would be necessary to derive a new and distinct file of multiple tumours from the main national cancer files. Each of the individual tumour registrations in a multiple record is already stored on those files, but the fact that they have been linked to the same person (at NHSCR) is not recorded. This fact is the only new item of information contained in each multiple record generated at NHSCR: it would have to be used to extract the necessary data for each of the individual tumours involved in a multiple record from their separate locations on the main national cancer files, and to merge all the data for that multiple record into one place. This approach to the creation of a data set of multiple tumours has a bearing on how the results of this study are interpreted. Those 'multiple' records which have already been detected as errors of registration and deleted from the main national cancer files ('inactive' records), but have not yet been excluded from among the existing files of multiple records, would not give rise to a multiple record in a data set derived in this way.
The accuracy of multiple primary tumour registration is 86 per cent within single registries, and only 8 per cent if two registries are involved: the great majority (89 per cent) of multiple records involving two registries are previously undetected duplicate registrations of one tumour. Since almost three-quarters of multiple tumour records do arise from a single registry, the logical first step in separating multiple primaries from registration errors would be to select records involving only one registry. Those sampled records still on the national files ('active' records) can be distributed in a two-way table, according to whether the record was a multiple primary or not, and whether one or two registries were involved (Table 4, derived from Table 3 ). This Table shows that selection of records arising from single registries would be expected to yield 96 per cent of all multiple primaries (244/253) and to exclude 73 percent of all registration errors (106/145). Multiple primaries would be expected to comprise 86 per cent (244/283) of this selection; the remainder would be errors. By further exclusion of records with non-specific sitecodes, with metastatic histology codes and with various clerical errors, it will be possible to create a body of data containing about 96 per cent of all recorded multiple primary tumours, and very few registration errors.
Further improvements in the national cancer registration system could be expected from routine surveillance at OPCS of multiple records received from NHSCR. Separation of multiple primaries from duplicates and other records could be automated on the basis of agreed criteria, after entry of the few relevant items of data from each multiple record into a computer file. This would involve a small volume of extra work in data entry (about 1200 multiples each month) but would rapidly bring several advantages.
First, duplicates could be referred back to the registries, a number of which indicated they would welcome such feedback from OPCS during the course of this study. The annual number of such duplicates may be roughly estimated at 1600: about 100 for each registry. This study suggests that 88 per cent of duplicate registrations received by OPCS currently escape detection, and that the simple scheme outlined here would enable most of them to be eliminated.
Second, systematic registration errors would be detected and quantified for the first time: the registries concerned would be able to improve the quality of their data. Suppression of duplicates at NHSCR should be discontinued, although duplicates detected there should be kept apart from other multiple records transmitted to OPCS. This would enable systematic errors revealed by these duplicates to be addressed by OPCS and the registries concerned.
Finally, this collection of data will rapidly become a large and increasingly useful source of data on multiple tumours. Since flagging only began in 1971, any second cancers arising since then in individuals with a previous, unfiagged cancer registration will not have been linked to the first tumour. The proportion of second cancers undetected for this reason will be expected to decay steadily, reaching zero when all surviving cancer patients have been registered since 1971, and flagged. For many cancers, survival beyond 10 or 12 years is still uncommon, and the OPCS multiple records may already be expected to contain virtually all second cancers that have arisen in these subjects since 1971. Such a complete, national and expanding data-set would be of considerable value in studying the epidemiology of multiple malignancy.
